Lantheus Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Lantheus Holdings, Inc. (LNTH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 196.52 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-02-26
- Lantheus Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2015-12-31 was 136.03K shares.
- Lantheus Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2015-09-30 was 355.87K shares.
- Lantheus Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 196.52K shares, a 162.22% increase from fiscal 2024.
- Lantheus Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 74.94K shares, a 112.15% increase from fiscal 2023.
- Lantheus Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 35.33K shares, a 94.56% increase from fiscal 2022.
- Lantheus Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 18.16K shares, a 93.60% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | 196.52K shares 10-K · filed 2026-02-26 | |||
| 2024-12-31 | 74.94K shares 10-K · filed 2025-02-26 | |||
| 2023-12-31 | 35.33K shares 10-K · filed 2024-02-22 | |||
| 2022-12-31 | 18.16K shares 10-K · filed 2023-02-23 | |||
| 2021-12-31 | 283.62K shares 10-K · filed 2022-02-24 | |||
| 2020-12-31 | 715.88K shares 10-K · filed 2021-02-25 | |||
| 2019-12-31 | 17.29K shares 10-K · filed 2020-02-25 | |||
| 2018-12-31 | 15.80K shares 10-K · filed 2019-02-20 | |||
| 2017-12-31 | 6.68K shares 10-K · filed 2018-02-26 | |||
| 2016-12-31 | 27.00K shares 10-K · filed 2017-02-23 | |||
| 2015-12-31 | 136.03K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-02 | 491.90K shares derived: sum of 2 quarters · filed 2016-03-02 | 592.18K shares 10-K · filed 2016-03-02 | |
| 2015-09-30 | 355.87K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | 456.15K shares 10-Q · filed 2015-11-04 | ||
| 2015-06-30 | 100.28K shares 10-Q · filed 2015-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |